Frontage Holdings Corp
HKEX:1521
Intrinsic Value
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. [ Read More ]
The intrinsic value of one
Frontage Holdings Corp
stock under the Base Case scenario is
3.03
HKD.
Compared to the current market price of 1.26 HKD,
Frontage Holdings Corp
is
Undervalued by 58%.
Frontage Holdings Corp's market capitalization is 2.6B HKD.
Frontage Holdings Corp stock price is 1.26 HKD.
Frontage Holdings Corp stock price (1.26 HKD) is 58% less than its Intrinsic Value (3.03 HKD).
Frontage Holdings Corp stock price (1.26 HKD) is 33% less than its DCF Value (1.88 HKD). Open DCF Valuation
Frontage Holdings Corp stock price (1.26 HKD) is 70% less than its Relative Value (4.17 HKD). Open Relative Valuation
Frontage Holdings Corp has upside potential of 57% compared to the average analyst price target.
Open Wall St Estimates
Frontage Holdings Corp has positive Net Income for the last twelve months.
Frontage Holdings Corp's Revenue has grown by 4% over the past 12 months.
Frontage Holdings Corp has positive Operating Income for the last twelve months.
Frontage Holdings Corp's ROE (Return on Equity) has decreased in the last 3 years from 6% to 3%.
Frontage Holdings Corp has positive three-year average ROIC (Return on Invested Capital): 8%. The company is efficient at using invested capital to generate operating income.
Frontage Holdings Corp's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
Frontage Holdings Corp has positive Free Cash Flow for the last twelve months.
Frontage Holdings Corp's ROE (Return on Equity) for the past 12 months is very low and is equal to 3%.
Frontage Holdings Corp's ROIC (Return on Invested Capital) has decreased in the last 3 years from 12% to 4%.
Frontage Holdings Corp has positive three-year average ROE (Return on Equity): 6%. The company is efficient at transforming stockholders' equity into net income.
Frontage Holdings Corp's short-term assets (142m USD) exceed its short-term liabilties (100m USD).
Frontage Holdings Corp's Revenue is forecast to grow at a rate of 19% per year over the next 3 years.
Frontage Holdings Corp has positive Net Debt. This means that the company has more debt (133m USD) than cash and short-term investments (55m USD).
Frontage Holdings Corp has positive Gross Profit for the last twelve months.
Frontage Holdings Corp's Revenue has been growing by an exceptional 27% per year for the last 3 years.
Frontage Holdings Corp's long-term assets (572m USD) exceed its long-term liabilties (229m USD).
Frontage Holdings Corp's D/E (Debt to Equity) is very low and is equal to 0.39.
Frontage Holdings Corp generates enough operating income (23m USD) to cover interest payments on its debt (6m USD).
Frontage Holdings Corp's Altman Z-Score is very high and is equal to 13.8.
Valuation Backtest
Frontage Holdings Corp
Run backtest to discover the historical profit from buying and selling
Frontage Holdings Corp
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Frontage Holdings Corp
Balance Sheet Decomposition
Frontage Holdings Corp
| Current Assets | 141.6m |
| Cash & Short-Term Investments | 54.6m |
| Receivables | 83.8m |
| Other Current Assets | 3.2m |
| Non-Current Assets | 430.3m |
| Long-Term Investments | 10.1m |
| PP&E | 183.8m |
| Intangibles | 221.1m |
| Other Non-Current Assets | 15.3m |
| Current Liabilities | 99.6m |
| Accounts Payable | 38.7m |
| Short-Term Debt | 20.1m |
| Other Current Liabilities | 40.7m |
| Non-Current Liabilities | 129.8m |
| Long-Term Debt | 113.3m |
| Other Non-Current Liabilities | 16.5m |
Earnings Waterfall
Frontage Holdings Corp
|
Revenue
|
259.9m
USD
|
|
Cost of Revenue
|
-181.5m
USD
|
|
Gross Profit
|
78.4m
USD
|
|
Operating Expenses
|
-55m
USD
|
|
Operating Income
|
23.4m
USD
|
|
Other Expenses
|
-12.6m
USD
|
|
Net Income
|
10.8m
USD
|
Free Cash Flow Analysis
Frontage Holdings Corp
Profitability Score
Profitability Due Diligence
Frontage Holdings Corp's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Score
Frontage Holdings Corp's profitability score is 52/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Frontage Holdings Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Score
Frontage Holdings Corp's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Frontage Holdings Corp
According to Wall Street analysts, the average 1-year price target for
Frontage Holdings Corp
is 1.98 HKD
with a low forecast of 1.52 HKD and a high forecast of 3.05 HKD.
Shareholder Return
Price
Frontage Holdings Corp
| Average Annual Return | -1.63% |
| Standard Deviation of Annual Returns | 21.57% |
| Max Drawdown | -86% |
| Market Capitalization | 2.6B HKD |
| Shares Outstanding | 2 035 719 936 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Frontage Holdings Corp
Country
Industry
Market Cap
Dividend Yield
Description
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.
Contact
IPO
Employees
Officers
The intrinsic value of one
Frontage Holdings Corp
stock under the Base Case scenario is
3.03
HKD.
Compared to the current market price of 1.26 HKD,
Frontage Holdings Corp
is
Undervalued by 58%.
You don't have any saved screeners yet
